支气管哮喘患者外周血中白细胞介素22水平的检测及其临床意义

doi:10.13481/j.1671-587x.20170226

吉林大学学报(医学版) ›› 2017, Vol. 43 ›› Issue (02): 349-352.doi: 10.13481/j.1671-587x.20170226

支气管哮喘患者外周血中白细胞介素22水平的检测及其临床意义

陈丽燕¹, 唐颖¹, 张俐², 斯琴¹, 许力军¹

1. 吉林大学第一医院呼吸内科, 吉林长春 130021;
2. 吉林大学第一医院儿科, 吉林长春 130021

收稿日期:2016-07-08 出版日期:2017-03-28 发布日期:2017-03-31
通讯作者: 许力军,教授,博士研究生导师(Tel:0431-88782305,E-mail:lijunxu001@sina.com) E-mail:lijunxu001@sina.com
作者简介:陈丽燕(1988-),女,山东省菏泽市人,在读医学硕士,主要从事支气管哮喘免疫机制及治疗方面的研究。
基金资助:
国家"863计划"资助课题（2006AAO2Z491）

Detection of interleukin -22 in peripheral blood of patients with bronchial asthma and its clinical significance

CHEN Liyan¹, TANG Ying¹, ZHANG Li², SI Qin¹, XU Lijun¹

1. Department of Respiratory Medicine, First Hospital, Jilin University, Changchun 130021, China;
2. Department of Pediatrics, First Hospital, Jilin University, Changchun 130021, China

Received:2016-07-08 Online:2017-03-28 Published:2017-03-31

摘要/Abstract

摘要： 目的：检测支气管哮喘患者外周血中白细胞介素22（IL-22）水平，分析其与免疫球蛋白E（IgE）、肺功能和呼出气一氧化氮（FENO）的关系，探讨IL-22在支气管哮喘发病中的作用。方法：选择78例支气管哮喘患者作为实验组，根据血浆IgE水平将支气管哮喘患者分为IgE升高组（n=46）和IgE正常组（n=32）；根据患者的临床症状将支气管哮喘患者分为急性发作期和临床缓解期；另外选择20名健康人作为对照组。检测各组受试者外周血中IL-22、IgE水平及第1秒用力呼气容积（FEV1）和FENO，比较各组受试者外周血中IL-22水平、FEV1和FENO水平的变化，并分析外周血中IL-22水平与IgE、FEV1和FENO水平的相关性。结果：哮喘组患者外周血血浆IL-22和FENO水平高于对照组（P<0.05），虽然临床缓解期患者IL-22和FENO水平低于急性发作期，但仍高于对照组（P<0.05）。IgE升高组患者血浆IL-22水平高于IgE正常组（P<0.05）。急性发作期和临床缓解期支气管哮喘患者IL-22水平与FEV1呈负相关关系（r=-0.3653，P<0.05；r=-0.2672，P<0.05），与FENO无相关关系（r=0.0119，P>0.05；r=0.0598，P>0.05）。结论：IL-22在支气管哮喘患者外周血中高表达，提示其可能参与支气管哮喘的发病机制，并可能加剧肺功能恶化。

关键词: 免疫球蛋白 E, 支气管哮喘, 白细胞介素22, 肺功能, 呼出气一氧化氮

Abstract: Objective: To detect the interleukin-22(IL-22) levels in peripheral blood of the asthma patients and analyze the relationship between the IL-22 levels and IgE,pulmonary function,fractional exhaled nitric oxide(FENO),and to investigate the role of IL-22 in the pathogenesis of bronchial asthma. Methods: Seventy-eight patients with asthma were selected as experiment group. The asthma patients were divided into increased IgE group (n=46)and normal IgE group(n=32)according to the IgE levels.The asthma patients were also divided into acute attack stage and clinical control stage according to patients' clinical symptoms.In addition, twenty healthy controls were chosen as healthy control group. The plasma IL-22 levels, IgE,forced expiratory volume in one second (FEV1) and FENO levels of the subjects in various groups were detected and compared between various groups. The correlations between the plasma IL-22 levels and IgE, FEV1,FENO were analyzed. Results: The plasma IL-22 level and FENO level of the patients in asthma group were higher than those in healthy control group(P<0.05).The IL-22 level and FENO level of the patients in clinical control stage were lower than those in acute attack stage,but they were still higher than those in healthy control group(P<0.05).The plasma IL-22 level of the patients in increased IgE group was higher than that in normal IgE group(P<0.05). There were significant negative correlations between the IL-22 levels and FEV1 in the asthma patients in acute attack group and clinical control group(r=-0.365 3,P<0.05;r=-0.267 2,P<0.05),but there was no significant correlation between the IL-22 levels and FENO(r=0.011 9,P>0.05;r=0.059 8,P>0.05). Conclusion: The increased expression of IL-22 in peripheral blood of the patients with asthma may participate in the pathogenesis of asthma,and may aggravate the deterioration of pulmonary function of the asthma patients.

Key words: immunoglobulin E, bronchial asthma, interleukin-22, pulmonary function, fractional exhaled nitric oxide

中图分类号:

R562.25

陈丽燕, 唐颖, 张俐, 斯琴, 许力军. 支气管哮喘患者外周血中白细胞介素22水平的检测及其临床意义[J]. 吉林大学学报(医学版), 2017, 43(02): 349-352.

CHEN Liyan, TANG Ying, ZHANG Li, SI Qin, XU Lijun. Detection of interleukin -22 in peripheral blood of patients with bronchial asthma and its clinical significance[J]. Journal of Jilin University Medicine Edition, 2017, 43(02): 349-352.

参考文献

[1] 中华医学会呼吸病学分会哮喘学组,中华医学会全科医学分会.中国支气管哮喘防治指南(基层版)[J].中国结核和呼吸杂志, 2013,36(5):331-336.
[2] Harper RW,Zeki AA.Immunobiology of the critical asthma syndrome[J].Clin Rev Allergy Immunol,2015,48(1):54-65.
[3] Manni ML, Alcorn JF. The enigmatic role of IL-22 in asthma[J]. Expert Rev Respir Med,2016,10(6):619-623.
[4] 孟颜,郭信长.白细胞介素-22、β-防御素-2与呼吸系统的免疫调节及哮喘关系的研究进展[J].国际免疫学杂志,2016,39(1):97-100.
[5] Dudakov JA,Hanash AM,van den Brink MR.Interleukin-22:immunobiology and pathology[J].Annu Rev Immunol,2015,33:747-785.
[6] Li JR,Zhou WX,Huang KW,et al.Interleukin-22 exacerbates airway inflammation induced by short-term exposure to cigarette smoke in mice[J].Acta Pharmacol Sin,2014,35(11):1393-1401.
[7] Perusina Lanfranca M,Lin Y,Fang J,et al.Biological and pathological activities of interleukin-22[J].J Mol Med (Berl),2016,94(5):523-534.
[8] Arasteh J,Ebtekar M,Pourpak Z,et al.The effect of IL-22 and IL-28 in induction of type 1 regulatory T (Tr1)cells [J].Iran J Allergy Asthma Immunol,2015,14(2):158-167.
[9] Lejeune D,Dumoutier L,Constantinescu S,et al.Interleukin-22(IL-22) activates the JAK/STAT,ERK,JNK,and p38 MAP kinase pathways in a rat hepatoma cell line.Pathways that are shared with and distinct from IL-10[J].J Biol Chem,2002,277(37):33676-33682.
[10] Taube C, Tertilt C, Gyülveszi G, et al. IL-22 is produced by innate lymphoid cells and limits inflammation in allergic airway disease[J].PLoS One,2011,6(7):e21799.
[11] Farfariello V,Amantini C,Nabissi M,et al.IL-22 mRNA in peripheral blood mononuclear cells from allergic rhinitic and asthmatic pediatric patients[J]. Pediatr Allergy Immunol,2011,22(4):419-423.
[12] 马继龙,彭经纬,王敏.IL-22的生物学效应及其在哮喘发病中的作用[J].医学综述,2013,19(11):1997-1999.
[13] Manni M L,Robinson K M,Alcorn J F.A tale of two cytokines:IL-17 and IL-22 in asthma and infection[J]. Expert Rev Respir Med,2014,8(1):25-42.
[14] Pennino D,Bhavsar PK,Effner R,et al.IL-22 suppresses IFN-γ-mediated lung inflammation in asthmatic patients[J]. J Allergy Clin Immunol,2013,131(2):562-570.
[15] Simpson JL,Scott R,Boyle MJ,et al.Inflammatory subtypes in asthma:assessment and identification using induced sputum[J].Respirology,2006,11(1):54-61.
[16] 史亮,赵海涛,孙丽,等.东北寒区作训官兵支气管哮喘流行病学调查分析[J]. 解放军医学杂志,2016,41(4):327-332.
[17] 谢华.支气管哮喘抗原免疫治疗最新研究进展[J]. 中国实用内科杂志,2016,36(8):621-624.
[18] 闫春玲.呼出气一氧化氮浓度测定对支气管哮喘诊断和治疗的意义[J].中国现代药物应用,2016,10(6):38-39.
[19] 支亚丽.支气管哮喘患者血清一氧化氮、内皮素、白介素-10、白介素-6和免疫球蛋白E变化的研究[J]. 实用医学杂志,2007,23(9):1323-1324.

支气管哮喘患者外周血中白细胞介素22水平的检测及其临床意义

Detection of interleukin -22 in peripheral blood of patients with bronchial asthma and its clinical significance

RichHTML

PDF (PC)

赞

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

Metrics

本文评价

推荐阅读 0

[1]	安倍莹, 李亚男, 具杨花, 王莹莹, 程航. 哮喘患儿血清中维生素D3水平对哮喘控制和肺功能的影响及其临床意义[J]. 吉林大学学报(医学版), 2018, 44(05): 1010-1013.
[2]	李星, 井弘宇, 陈立婷, 李丹, 钱东华. 慢性咳嗽患者血清中IL-17、IL-33水平和FeNO浓度检测及其临床意义[J]. 吉林大学学报(医学版), 2018, 44(01): 126-130.
[3]	张雪阳, 马骥, 孟广平, 王琦, 李伟, 徐艳玲, 张捷, 高鹏. 基于吉林省长春市区居民肺功能筛查的慢性阻塞性肺疾病患病现况调查分析[J]. 吉林大学学报(医学版), 2017, 43(05): 1047-1052.
[4]	李艳凤, 王洪波, 高阳, 郑雨轩, 刘丽. 支气管哮喘患儿血清骨膜蛋白水平变化及其意义[J]. 吉林大学学报(医学版), 2017, 43(01): 101-105.
[5]	陈洪涛, 杨智, 吴诗品. 慢性乙肝病毒感染各阶段患者外周血单个核细胞中IL-22mRNA的表达水平及其临床意义[J]. 吉林大学学报(医学版), 2016, 42(03): 551-555.
[6]	赵大辉, 张鹏, 汪建国, 王峰, 曹璐, 李玉香. 先天性脊柱侧弯与特发性脊柱侧弯对肺功能影响的对比分析[J]. 吉林大学学报(医学版), 2016, 42(02): 326-330.
[7]	陈敏，赖天文，招轩娜，吕莹莹，高拯妮，黄丹，刘升明. CHI3L1基因多态性和血清YKL-40水平与支气管哮喘发病的关联性[J]. 吉林大学学报(医学版), 2014, 40(05): 1058-1063.
[8]	徐晓光，姜振宇，杜敏娟，杨亚琴，蒋颖超. 沙美特罗/丙酸氟替卡松联合N-乙酰半胱氨酸治疗慢性阻塞性肺疾病的疗效评价[J]. 吉林大学学报(医学版), 2014, 40(04): 870-874.
[9]	赵令,马宁,刘涛,姜振宇. 系统性红斑狼疮患者外周血辅助性T细胞亚型和细胞因子的检测及其临床意义[J]. 吉林大学学报(医学版), 2014, 40(02): 399-403.
[10]	孙博文，唐颖，李晓丹，许力军. 支气管哮喘患者外周血中IL-33水平的检测及其在支气管哮喘发病机制中的作用[J]. 吉林大学学报(医学版), 2014, 40(02): 395-398.
[11]	郭晓雪，马丽伟，李晓宁，刘颖，孙璐瑶，张连莲，于振香. 乙酰半胱氨酸联合异丙托溴铵对控制大鼠慢性阻塞性肺疾病病程进展的作用[J]. 吉林大学学报(医学版), 2013, 39(4): 694-698.
[12]	张力文，张云峰，尤海龙，刘丽，尹嘉宁. 长期舌下含服粉尘螨滴剂治疗儿童支气管哮喘的有效性和安全性评价[J]. 吉林大学学报(医学版), 2013, 39(1): 148-151.
[13]	王秀华\|刘丽\|乔红梅\|李亚男\|卢清华\|成焕吉. 特应性和非特应性哮喘患儿血清白细胞介素-10和血浆内皮素-1表达水平的检测及其临床意义[J]. J4, 2012, 38(3): 547-550.
[14]	唐颖\|丛中凰\|李晓丹\|许力军. 布地奈德/福莫特罗粉吸入治疗对支气管哮喘患者肺功能改善作用及血清细胞因子的影响[J]. J4, 2012, 38(1): 131-134.
[15]	李晓丹\|许力军\|刘超英\|邹奇\|丛中凰\|王满\|张洪泉. 联合雾化吸入治疗急性发作期支气管哮喘患者的效果评价[J]. J4, 2011, 37(6): 1120-1123.